PROOF: Plaque Removal Versus Open Bypass Surgery For Critical Limb Ischemia

Sponsor
FoxHollow Technologies (Industry)
Overall Status
Terminated
CT.gov ID
NCT00504088
Collaborator
(none)
31

Study Details

Study Description

Brief Summary

To compare the outcome of bypass surgery and plaque excision for treatment of critical limb ischemia in the lower limbs

Condition or Disease Intervention/Treatment Phase
  • Procedure: Bypass
  • Procedure: Silverhawk Plaque Excision
Phase 4

Study Design

Study Type:
Interventional
Allocation:
Randomized
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Plaque Removal Versus Open Bypass Surgery For Critical Limb Ischemia
Study Start Date :
Oct 1, 2006

Outcome Measures

Primary Outcome Measures

  1. Major amputation-free survival []

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Ischemic rest pain for more than 2 weeks or ulceration or gangrene of the foot or toes (Rutherford Becker Category 4, 5 or 6)

  • Willing and able, as evaluated by the PI, to provide Informed Consent

  • Willing to undergo up to 5 years of clinical follow up visits as scheduled

  • Angiographic pattern of infrainguinal disease that can be reasonably managed either by surgery or plaque excision in the first instance

  • Reconstitution of at least one patent target tibial segment below the knee which provides run-off to the foot

  • The patient must be >18 years of age

  • Target lesion(s) is located at or below the level of the superficial femoral artery

  • Target lesion(s) is >50% stenosed by quantitative vascular angiography

  • Ability to take at least one of the following types of medications: anti- platelet or anti-thrombotic therapy

Exclusion Criteria:
  • Patient has cardiac or cardiovascular comorbidities that would make surgery inappropriate

  • Patient has terminal or Stage 4 cancer

  • Patient has extensive gangrene that requires both a Below-the-Knee amputation and a revascularization procedure

  • Previous stent in the target lesion

  • Active infection at planned incision site

  • The patient is a pregnant woman

  • The patient has significant suprainguinal or Common Femoral disease that can not be treated either prior to or during the index procedure

  • Target Lesion is a Chronic Total Occlusion (CTO) that is greater than 15cm in length and has severe, continuous calcification

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of Alabama, Birmingham Birmingham Alabama United States 35294
2 Los Angeles Cardiology/Good Samaritan Los Angeles California United States 90017
3 UC Davis Vascular Center Sacramento California United States 95817
4 San Francisco VA Medical Center San Francisco California United States 94121
5 Stanford University Medical Center/Palo Alto VA Stanford California United States 94306
6 Heart & Vascular Clinic of Northern Colorado Fort Collins Colorado United States 80523
7 Holmes Regional Medical Center Melbourne Florida United States 32901
8 Sacred Heart Hospital Pensacola Florida United States 32504
9 University of Chicago Chicago Illinois United States 60637
10 Advocate Christ Medical Center Oak Lawn Illinois United States 60453
11 St. Vincent Indianapolis Indiana United States 46260
12 Iowa Methodist Medical Center Des Moines Iowa United States 50309
13 Vascular Surgery Associates Baton Rouge Louisiana United States 70809
14 Beth Isreal (BIDMC) Boston Massachusetts United States 02215
15 St. Vincent Hospital Worchester Massachusetts United States 01608
16 William Beaumont/Southeast Surgical Royal Oak Michigan United States 48073
17 Providence Hospital Southfield Michigan United States 48075
18 University of Mississippi Jackson Mississippi United States 39216
19 Alegent Health Research Center Omaha Nebraska United States 68152
20 Hackensack University Medical Center Hackensack New Jersey United States 07601
21 New Mexico Heart Institute, PA Albuquerque New Mexico United States 87102
22 St. Vincent's Medical Center New York New York United States 10011
23 NY Weill Cornell Medical Center New York New York United States 10021
24 Columbia Presbyterian New York New York United States 10604
25 Duke University Medical Center Durham North Carolina United States 27712
26 Cleveland VAMC Cleveland Ohio United States 44106
27 Thomas Jefferson University Hospital Philadelphia Pennsylvania United States 19107
28 Rhode Island Hospital Providence Rhode Island United States 02903
29 Vanderbilt University Medical Center Nashville Tennessee United States 37232
30 Sentara Heart Hospital Norfolk Virginia United States 23507
31 Madigan Army Medical Center Tacoma Washington United States 98431

Sponsors and Collaborators

  • FoxHollow Technologies

Investigators

  • Principal Investigator: James F. McKinsey, M.D., Columbia University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
, ,
ClinicalTrials.gov Identifier:
NCT00504088
Other Study ID Numbers:
  • FHT-P-06-003
First Posted:
Jul 19, 2007
Last Update Posted:
Aug 20, 2008
Last Verified:
Aug 1, 2007

Study Results

No Results Posted as of Aug 20, 2008